Spur Therapeutics’ Post

Recent advancements have accelerated cell and gene therapy development, leading to more clinical trials and approvals. Discover the transformative tools and techniques from this exciting field detailed in our new eBook. #CellTherapy #GeneTherapy https://lnkd.in/gBUkzSGV

The approval of CRISPR gene therapy for sickle cell disease (SCD) is a huge advancement in medical science! Individuals living with SCD often experience life-long chronic pain, and on top of that, they're often not expected to live past their 40s, but new gene therapies could completely transform patients' lives. But this is only if these therapies become accessible to the average person. SCD affects Black patients far more than any other group, and these extremely expensive treatments are incredibly difficult to afford for nearly anyone, especially economically marginalized groups. #CRISPR #GeneTherapy #SickleCell #SCD #Healthcare https://lnkd.in/grsshkKy

Cell and gene therapies have the potential to provide long-term therapeutic efficacy, but their development is both risky and cost-intensive. ⚠️ Check out 6️⃣ analytical strategies to consider before submitting your cell and gene therapy application. #biopharma #celltherapy #genetherapy

Catalent Cell & Gene Therapy experts discuss how cell and gene therapies are changing the healthcare landscape and what needs to be done to bring these advanced therapies to patients. https://ow.ly/2CZW50QSEkX

CRISPR Gene therapy restores vision in inherited blindness trial. Researchers have made significant strides in using CRISPR gene editing to treat Leber congenital amaurosis (LCA), a rare inherited retinal disease that leads to blindness. The experimental therapy, delivered directly to the eye, targets a common genetic cause of Leber Congenital Amaurosis. Patients reported better visual acuity, light perception, navigation, and quality of life. The treatment was safe, providing proof-of-concept for CRISPR gene therapies to treat inherited retinal diseases and potentially other genetic disorders. Read more: https://lnkd.in/gmjv7UJ6 #medical #genetherapy #CRISPR #blindness #biology

There's exciting news in the world of cell and gene therapy! Learn from experts about the latest advancements and increasing approvals of gene therapies, as well as their primary barriers and challenges. Healthcare organizations can also begin preparing now to manage them with insights from the new Vizient Pharmacy Market Outlook: https://viz.inc/46GeDzi.

Why choose RNAscope? Simply because this is the only reliable technology that can be used to visualize vector distribution, quantify transgene expression and at the end of the day help evaluating therapeutic effictiveness. Already used by numerous gene therapy companies, you can do it as well. #RNAscope #genetherapy

🧬 The EAHAD Gene Therapy Trials Database has just been updated! Dive into the latest clinical trial results in #haemophilia and allied disorders: https://lnkd.in/egjgFK23 Our database is freely available and publicly accessible, making it your go-to source for cutting-edge information. 🔍 Explore the updates now!

There's exciting news in the world of cell and gene therapy! Learn from experts about the latest advancements and increasing approvals of gene therapies, as well as their primary barriers and challenges. Healthcare organizations can also begin preparing now to manage them with insights from the new Vizient Pharmacy Market Outlook: https://viz.inc/46GeDzi.

Ying Xiong, PhD, who directs our Cell and Gene Therapy program and our Scientific Director, Rimas Orentas, PhD, made key presentations at #ASGCT24. Ying presented an oral abstract in the Novel Production Platforms Session demonstrating our cost-effective CAR-T manufacturing process and Rimas presented in a symposium focused on enabling analytics for point-of-care manufacturing. Their presentations highlight our work to enhance access to Cell and Gene Therapy world-wide. #GlobalHealth #CGT #PatientAccess American Society of Gene & Cell Therapy Global Gene Therapy Initiative